---
title: "Shanghai Int Medical Instruments invests in Broncus Holding through new share subscription"
description: "Shanghai Int Medical Instruments Co. Ltd. has announced a transaction involving the subscription of 91,093,613 new shares in Broncus Holding Corporation, formalized through a subscription agreement da"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/260611071.md"
published_at: "2025-10-10T11:03:21.000Z"
---

# Shanghai Int Medical Instruments invests in Broncus Holding through new share subscription

> Shanghai Int Medical Instruments Co. Ltd. has announced a transaction involving the subscription of 91,093,613 new shares in Broncus Holding Corporation, formalized through a subscription agreement dated October 10, 2025. Broncus, listed on the Hong Kong Stock Exchange, specializes in interventional pulmonology devices. The completion of the transaction is subject to certain conditions outlined in the agreement.

Shanghai Int Medical Instruments Co. Ltd. has announced a discloseable transaction involving the subscription of 91,093,613 new shares in Broncus Holding Corporation. The investment was formalized through a subscription agreement dated 10 October 2025. Broncus, listed on the Hong Kong Stock Exchange, is a Cayman Islands-incorporated company specializing in interventional pulmonology devices for lung disease diagnosis and treatment. The completion of the transaction is subject to the satisfaction or waiver of conditions precedent outlined in the agreement. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Int Medical Instruments Co. Ltd. published the original content used to generate this news brief on October 10, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [02216.HK - BRONCUS-B](https://longbridge.com/en/quote/02216.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 堃博控股的 BroncTarget 系统进入国家药品监督管理局创新医疗器械特别审查程序 | Broncus Holding Corporation 的 BroncTarget®系统已进入中国国家药品监督管理局的创新医疗器械特别审查程序。该系统被称为肺部射频消融系统，以其技术原创性和临床价值而受到认可。目前在中国 28 家医院正在进 | [Link](https://longbridge.com/en/news/272272640.md) |
| 堃博控股公司以 1500 万美元收购目标公司的股份 | Broncus Holding Corporation 的子公司已签署股份转让协议，以 1500 万美元收购一家目标公司的股份。该协议日期为 2025 年 12 月 29 日，受限于包括交割时陈述的准确性等条件。预计收购将在 2026 年  | [Link](https://longbridge.com/en/news/271002934.md) |
| 新春伊始，如何看待人民币升值？ | 人民币汇率在 2023 年 2 月 12 日突破 6.9 关口，创 33 个月新高。尽管一些国家指责人民币汇率低估影响贸易，但市场对人民币资产的看法已转变，开始关注哪些中国资产值得投资。美元走弱是人民币升值的背景之一，但人民币升值的节奏还需 | [Link](https://longbridge.com/en/news/276026949.md) |
| Baxter｜10-K：2025 财年营收 112 亿美元超过预期 |  | [Link](https://longbridge.com/en/news/275813380.md) |
| 德康医疗｜8-K：2025 财年 Q4 营收 12.6 亿美元超过预期 |  | [Link](https://longbridge.com/en/news/275807118.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.